Home » FDA Issues Safety Alert for Texas Compounder's Products
FDA Issues Safety Alert for Texas Compounder's Products
The FDA asked healthcare professionals to watch out for drugs compounded by a Dallas-based pharmacy after a recent inspection revealed 22 lots of sterile drugs failed quality tests.
Drug GMP Report
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct